Skip to main content
letter
. 2021 Mar 12;23(7):1696–1700. doi: 10.1111/dom.14359

FIGURE 2.

FIGURE 2

Effect of sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors compared with placebo on the risk for A, pneumonia, B, pharyngitis and C, bronchitis